Prozac, a common medication used to combat depression, has been found to be less effective on patients with a specific gene set. People who have taken Prozac for two months but have shown no sign of improvement should opt for another treatment, says a medical report released by the Taipei Veterans General Hospital (TVGH). Tsai Shih-jen (蔡世仁), section chief of General Psychiatry at TVGH, said those with major depression carry genes that mitigate serotonin reuptake transporters, enhance monoamine oxidase, disrupt brain-derived neurotrophic factors, or generate serotonin 1A receptors that are more likely to be "Prozac-resistant."
Fri, Nov 17, 2006 - Page 3 News List
Taiwan Quick Take: Limitations found for Prozac
STAFF WRITER WITH AGENCIES
This story has been viewed 2007 times.
Listing from 2015-04-13 to 2015-04-20
- Most read
- Most e-mailed
1Local ‘Free The Nipple’ photoshoot sparks controversy
2European stocks retreat on Greek financing woes
3South African power cuts extended for seventh day
4Suicide bomber kills 33 in attack outside Afghanistan bank
5Tsai dismisses KMT criticism